Philips North America has been the subject of 355 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for Bristol-Myers Squibb Company.
Bristol-Myers Squibb Company: 0 warning letters, 1 recall, 0 approval records, 0 Form 483s.
Philips North America: 0 warning letters, 355 recalls, 0 approval records, 0 Form 483s.
Side by side
Bristol-Myers Squibb Company — Warning letters0
Philips North America — Warning letters0
Bristol-Myers Squibb Company — Recalls1
Philips North America — Recalls355
Bristol-Myers Squibb Company — Approval records0
Philips North America — Approval records0
Bristol-Myers Squibb Company — Form 483s0
Philips North America — Form 483s0
Timeline
Cite this comparison
Pre-formatted for a story, footnote, or reference list:
"Bristol-Myers Squibb Company vs Philips North America: FDA Enforcement Comparison." Argus HQ, accessed July 17, 2026. https://argushq.ai/compare/bristol-myers-squibb-company-vs-philips-north-america
Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗